Enfermedades Cardiovasculares
Buscador de publicaciones
Sólo se han incluido artículos originales, editoriales y revisiones.
-
Zamorano JL, Gonçalves A.
Three dimensional echocardiography for quantification of valvular heart disease
Heart . 99(11): 811-818. Nº de citas: 6
-
Hradec J, Zamorano J, Sutradhar S.
Post hoc analysis of the Cluster Randomized Usual Care versus Caduet Investigation Assessing Long-term risk (CRUCIAL) trial
CURRENT MEDICAL RESEARCH AND OPINION . 29(6): 589-596. Nº de citas: 10
-
Barrios V, Escobar C.
Rosuvastatin and diabetes: when the evidences talk.
Cardiovascular & hematological agents in medicinal chemistry . 11(2): 115-124.
-
Hernández-Madrid A, Svendsen JH, Lip GY, Van Gelder IC, Dobreanu D, Blomstrom-Lundqvist C.
Cardioversion for atrial fibrillation in current European practice: results of the European Heart Rhythm Association survey
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology . 15(6): 915-918. Nº de citas: 32
-
González-Corrochano R, La Fuente J, Cuevas P, Fernández A, Chen M, Sáenz de Tejada I, Angulo J.
Ca2+-activated K+ channel (K-Ca) stimulation improves relaxant capacity of PDE5 inhibitors in human penile arteries and recovers the reduced efficacy of PDE5 inhibition in diabetic erectile dysfunction
BRITISH JOURNAL OF PHARMACOLOGY . 169(2): 449-461. Nº de citas: 33
-
Kim JH, Zamorano J, Erdine S, Pavia A, Al-Khadra A, Sutradhar S, Yunis C.
Reduction in cardiovascular risk using proactive multifactorial intervention versus usual care in younger (< 65 years) and older (>= 65 years) patients in the CRUCIAL trial
CURRENT MEDICAL RESEARCH AND OPINION . 29(5): 453-463. Nº de citas: 4
-
Perk J, De Backer G, Gohlke H, Graham I, Reiner Z, Verschuren WM, Albus C, Benlian P, Boysen G, Cifkova R, Deaton C, Ebrahim S, Fisher M, Germanò G, Hobbs R, Hoes A, Karadeniz S, Mezzani A, Prescott E, Ryden L, Scherer M, Syvanne M, Scholte Op Reimer WJ, Vrints C, Wood D, Zamorano JL, Zannad F.
[European Guidelines on Cardiovascular Disease Prevention in Clinical Practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts)].
Giornale italiano di cardiologia (2006) . 14(5): 328-392.
-
Barrios V, Escobar C.
Can dabigatran improve blood pressure control?
Future cardiology . 9(3): 321-323.
-
Miglioranza MH, Leiria TL, Haertel JC, Winkler M, Fernández-Golfin C, Zamorano JL.
The Role of Three-Dimensional Echocardiography in Interventricular Mass Evaluation
ECHOCARDIOGRAPHY-A JOURNAL OF CARDIOVASCULAR ULTRASOUND AND ALLIED TECHNIQUES . 30(5): 125-127. Nº de citas: 3
-
Almenar L, Zunzunegui JL, Barón G, Carrasco JI, Gómez-Doblas JJ, Comín J, Barrios V, Subirana MT, Díaz-Molina B.
Update on Heart Failure, Heart Transplant, Congenital Heart Disease, and Clinical Cardiology
REVISTA ESPANOLA DE CARDIOLOGIA . 66(4): 290-297. Nº de citas: 5
-
Lancellotti P, Badano LP, Lang RM, Akhaladze N, Athanassopoulos GD, Barone D, Baroni M, Cardim N, Gomez de Diego JJ, Derumeaux G, Dulgheru R, Edvardsen T, Galderisi M, Gonçalves A, Habib G, Hagendorff A, Hristova K, Kou S, Lopez T, Magne J, de la Morena G, Popescu BA, Penicka M, Rasit T, Rodrigo Carbonero JD, Salustri A, Van de Veire N, von Bardeleben RS, Vinereanu D, Voigt JU, Voilliot D, Zamorano JL, Donal E, Maurer G.
Normal Reference Ranges for Echocardiography: rationale, study design, and methodology (NORRE Study)
EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING . 14(4): 303-308. Nº de citas: 75
-
Brotons C, Lobos JM, Royo-Bordonada MÁ, Maiques A, de Santiago A, Castellanos Á, Diaz S, Obaya JC, Pedro-Botet J, Moral I, Lizarbe V, Moreno R, Pérez A, Cordero A, Fornés-Ubeda F, Serrano-Saiz B, Camafort-Babkowski M, Elosua R, Sans S, de Pablo C, Gil-Nuñez A, de Álvaro-Moreno F, Armario P, Rico OC, Villar F, Lizcano Á.
Implementation of Spanish adaptation of the European guidelines on cardiovascular disease prevention in primary care
BMC FAMILY PRACTICE . 14: 36-36. Nº de citas: 25
-
Pinneri F, Frea S, Najd K, Panella S, Franco E, Conti V, Corgnati G.
Echocardiography-guided versus fluoroscopy-guided temporary pacing in the emergency setting: an observational study
JOURNAL OF CARDIOVASCULAR MEDICINE . 14(3): 242-246. Nº de citas: 7
-
Vahanian A, Alfieri O, Andreotti F, Antunes MJ, Baron-Esquivias G, Baumgartner H, Borger MA, Carrel TP, De Bonis M, Evangelista A, Falk V, Iung B, Lancellotti P, Pierard L, Price S, Schafers HJ, Schuler G, Stepinska J, Swedberg K, Takkenberg J, Von Oppell UO, Windecker S, Zamorano JL, Zembala M.
[Guidelines on the management of valvular heart disease (version 2012). The Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)].
Giornale italiano di cardiologia (2006) . 14(3): 167-214.
-
Escaned J, Echavarría-Pinto M, Gorgadze T, Gonzalo N, Armengol F, Hernández R, Jiménez-Quevedo P, Nuñez-Gil IJ, Pérez-Vizcayno MJ, Alfonso F, Bañuelos C, Ibañez B, García E, Fernández-Ortiz A, Macaya C.
Safety of lone thrombus aspiration without concomitant coronary stenting in selected patients with acute myocardial infarction
EUROINTERVENTION . 8(10): 1149-1156. Nº de citas: 21
-
Barrios V, Escobar C, SANMARTIN FERNANDEZ, MARCELO.
Rivaroxaban: a once-daily anticoagulant for the prevention of thromboembolic complications.
Expert review of cardiovascular therapy . 11(2): 129-141.
-
García Martín A, Moya Mur JL, Fernández Golfín C, Zamorano Gómez JL.
Carcinoid heart disease: the winking heart.
Heart Asia . 5(1): 233-234.
-
Dias A, Franco E, Mercedes A, Hebert K, Messina D, Quevedo HC.
Clinical Features of Takotsubo Cardiomyopathy - A Single-Center Experience
Cardiology . 126(2): 126-130. Nº de citas: 12